2005
DOI: 10.1002/jid.1231
|View full text |Cite
|
Sign up to set email alerts
|

Science and governance of modern biotechnology in Sub‐Saharan Africa—the case of Uganda

Abstract: Science policy, particularly as it applies to biotechnology and biosafety, has no single 'correct' approach to follow. An objective approach to biotechnology policy however requires three essential components: scientific advice, the engagement of a range of stakeholders in policy dialogue, and effective governance at a systemic level, in an 'innovation systems' sense, forming closer interaction between organizations and personnel to ensure that knowledge flows are maintained at all times. The article discusses… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 3 publications
0
9
0
Order By: Relevance
“…Documents produced by the Common Market for Eastern and Southern Africa (Gachenga, ) and the African Union (Juma & Serageldin, ) celebrate the potential for GMOs to transform agricultural production, calling for increased capacity building, more open regulatory systems and greater investment to maximise their potential. Scholarly research has argued for an ‘objective’ approach to biotechnology policy that will maximise benefits to all users (Wafula & Clark, ; Kingiri & Hall, ). However, these observations and analyses focus almost exclusively on what governments should do to facilitate the regulation and approval of GM crops; they do not explain how or why interests come together to produce a particular regulatory path.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Documents produced by the Common Market for Eastern and Southern Africa (Gachenga, ) and the African Union (Juma & Serageldin, ) celebrate the potential for GMOs to transform agricultural production, calling for increased capacity building, more open regulatory systems and greater investment to maximise their potential. Scholarly research has argued for an ‘objective’ approach to biotechnology policy that will maximise benefits to all users (Wafula & Clark, ; Kingiri & Hall, ). However, these observations and analyses focus almost exclusively on what governments should do to facilitate the regulation and approval of GM crops; they do not explain how or why interests come together to produce a particular regulatory path.…”
Section: Introductionmentioning
confidence: 99%
“…First, existing accounts insufficiently recognise how power and politics shape the governance of new biotechnologies (Harsh & Smith, ). To date, evaluations of policy and regulatory processes of GM crops in Kenya (Kingiri, ) and Uganda (Wafula & Clark, ) suggest that the scientific and technical capacity to evaluate risks of GM crops has been weak but improving, particularly as a result of partnerships with private firms and international organisations. However, as others have pointed out, these relationships are not neutral: ‘Partnerships should be seen for what they are: relationships, often unequal, where each partner strives to serve its own interests first and the outcomes of the partnership second’ (Crewe & Harrison, in Smith, : 651; Harsh, ).…”
Section: Introductionmentioning
confidence: 99%
“…3. Uganda has been partnering research centres in other countries for development of GM banana since 2002 (Wafula and Clark, 2005). An application was recently made to import a genetically modified banana into Uganda for confined trials (Nakkazi, 2007 …”
Section: Notesmentioning
confidence: 98%
“…Again regional comparison is enlightening. Uganda has taken the position that no GM research or trials shall occur until a policy and regulatory legislation are prepared and approved (Wafula and Clark, 2005).…”
Section: A Biotechnology Hub For Sub-saharan Africamentioning
confidence: 99%
“…Within this theme, several papers discuss the types of national polices needed to facilitate smallholder adoption of GM crops and how to strengthen national plant-breeding institutions (e.g., References [50,51]). Another theme in the Africa literature concerned different regulatory approaches, how to raise biotech capacity in Africa and the potential economic effects at the national level of more restrictive and proactive policies on biotechnology [52,53]. A few papers discuss the effects of EU and US policy-making on African countries.…”
Section: Policy and Market Issues Researched In Africa And Europementioning
confidence: 99%